Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hcgoncology.com | |
Market Cap | 4,460.69 Cr. | |
Enterprise Value(EV) | 4,663.38 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.11 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 151.18 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 48.14 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 61.84 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 5.15 | Calculated using Price: 318.75 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 13.92 Cr. | 139,157,312 Shares |
FaceValue | 10 | |
About Healthcare Global Enterprises Ltd. | ||
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand. |
1 Day |
|
-0.16% |
1 Week |
|
+3.85% |
1 Month |
|
+19.83% |
3 Month |
|
+15.00% |
6 Month |
|
+4.90% |
1 Year |
|
+11.99% |
2 Year |
|
+71.90% |
5 Year |
|
+10.48% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -15.10 | 1.75 | 0.64 | 5.38 | 3.71 | -6.48 | -29.68 | -43.32 | 5.16 | |
Return on Capital Employed (%) | -0.71 | 6.41 | 5.60 | 7.22 | 7.59 | 3.46 | 1.65 | -9.66 | 15.17 | |
Return on Assets (%) | -5.91 | 0.64 | 0.25 | 2.06 | 1.29 | -2.03 | -6.51 | -10.46 | 1.85 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 263 | 279 | 426 | 433 | 515 | 477 | 381 | 697 | 870 | 861 | |
Non Curr. Liab. | 257 | 279 | 306 | 354 | 483 | 557 | 1,232 | 822 | 860 | 871 | |
Curr. Liab. | 149 | 187 | 263 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | |
Minority Int. | 18 | 25 | 33 | 57 | 64 | 46 | 39 | 17 | 13 | 9 | |
Equity & Liab. | 688 | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 | |
Non Curr. Assets | 578 | 648 | 800 | 966 | 1,200 | 1,354 | 1,923 | 1,566 | 1,711 | 1,730 | |
Curr. Assets | 109 | 122 | 227 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 688 | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 450 | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,694 | |
Other Income | 5 | 5 | 4 | 10 | 19 | 10 | 10 | 21 | 16 | 13 | |
Total Income | 455 | 524 | 588 | 710 | 848 | 986 | 1,103 | 1,030 | 1,410 | 1,708 | |
Total Expenditure | -413 | -443 | -499 | -595 | -716 | -853 | -923 | -887 | -1,160 | -1,396 | |
PBIDT | 42 | 81 | 89 | 115 | 132 | 133 | 179 | 144 | 251 | 312 | |
Interest | -32 | -34 | -38 | -23 | -42 | -70 | -138 | -119 | -98 | -104 | |
Depreciation | -36 | -39 | -44 | -57 | -71 | -85 | -148 | -159 | -158 | -163 | |
Taxation | -5 | 2 | 2 | -12 | -10 | 3 | -6 | 8 | -49 | -27 | |
Exceptional Items | -10 | -5 | -6 | 11 | -93 | 95 | |||||
PAT | -42 | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | |
Minority Interest | -2 | -4 | -4 | -1 | 4 | 6 | 19 | 28 | 15 | 12 | |
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -44 | 1 | -1 | 22 | 21 | -25 | -107 | -193 | 54 | 29 | |
Adjusted EPS | -6 | 0 | 0 | 3 | 2 | -3 | -12 | -15 | 4 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 29 | 50 | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | |
Cash Fr. Inv. | -100 | -58 | -80 | -204 | -210 | -282 | -238 | -101 | -171 | 125 | |
Cash Fr. Finan. | 66 | 23 | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | |
Net Change | -6 | 15 | 2 | 85 | -29 | -23 | -56 | -30 | 62 | 190 | |
Cash & Cash Eqvt | 11 | 25 | 25 | 80 | 51 | 27 | -29 | -59 | 3 | 193 |
Fri, 02 Jun 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Tue, 30 May 2023
Updates
|
|
Mon, 29 May 2023
Updates
|
Mon, 05 Jun 2023 |
|
|
|
|
|